Segmente 2022

in TCHF

Plasma
Control
Technologies
(PCT)

X-Ray
Systems
(IXS)

Industrial
X-Ray
Modules
(IXM)

Elimination
Aktivitäten
mit
anderen
Segmenten

Corporate

Total Gruppe

Nettoumsatz

           
Nettoumsatz mit Drittkunden 381,424 129,944 75,026 586,395
Umsatz mit anderen Segmenten 407 13,616 (14,023)

Total Nettoumsatz

381,424 130,351 88,643 (14,023) 586,395

Segmentergebnis

94,497 (3,104) 10,868 (1,227) 101,033
Nicht direkt zugewiesene Kosten (2,059) (2,059)

Betriebsergebnis

94,497 (3,104) 10,868 (1,227) (2,059) 98,975
Zinsertrag 440
Zinsaufwand (1,715)
Gewinne/Verluste aus FairValue-Bewertung Derivaten, netto (192)
Fremdwährungsgewinne/-verluste, netto (2,140)

Gewinn vor Steuern

95,368
Ertragssteuern (17,259)

Reingewinn

78,109
             

EBITDA

104,915 1,607 15,677 (1,227) (2,059) 118,913
EBITDA in % vom Nettoumsatz 27.5% 1.2% 17.7%     20.3%
             

Aktiven und Passiven zum 31.12.2022

           
Segmentaktiven 216,730 103,496 88,108 148.467 556,801
Segmentverbindlichkeiten (75,364) (53,689) (17,222) (78,994) (225,269)

Nettoaktiven

141,365 49,807 70,886 69,473 331,532

Übrige Segmentinformationen

           
Investitionen Nutzungsrechte aus Leasing 20,714 1,558 239 22,511
Investitionen Sachanlagen und immaterielle Werte 16,958 2,384 3,412 22,753
Abschreibungen, Amortisationen und Wertberichtigungen 10,419 4,711 4,809 19,939
Veränderung Rückstellungen (318) 1,509 (166) 1,026
Übriger nicht liquiditätswirksamer
Aufwand/Ertrag
(345) 93 4 58 24 (166)
Personalbestand am Jahresende 998 430 335 1,763

Segmente
2021

in TCHF
Plasma Control
Technologies
(PCT)
X-Ray
Systems
(IXS)
Industrial
X-Ray Modules
(IXM)
ebeam Technologies (EBT) Elimination Umsatz mit anderen Segmenten Corporate Total Gruppe
         

Nettoumsatz

             
Nettoumsatz mit Drittkunden 306’091 138’371 69’259 513’721
Umsatz mit anderen Segmenten 535 9’687 -10’222
Total Nettoumsatz 306’091 138’906 78’946 -10’222 513’721

Resultate

             
Segmentergebnis 71’864 3’634 10’548 294 86’340
Nicht direkt zugewiesene Kosten -2’255 -2’255
Betriebsergebnis 71’864 3’634 10’548 294 -2’255 84’085
Finanzaufwand             -5’106
Finanzertrag             3’229
Gewinn vor Steuern             82’208
Ertragssteuern             -14’771

Reingewinn

            67’437
               

EBITDA

80’487 8’931 15’292 294 -2’255 102’749
EBITDA in % vom Nettoumsatz 26.3% 6.4% 19.4%       20.0%
               

Aktiven und Passiven zum 31.12.2021

             
Segmentaktiven 153’907 116’142 85’470 134’897 490’415
Segmentverbindlichkeiten -50’890 -75’497 -20’290 -68’757 -215’435

Nettoaktiven

103’017 40’645 65’180 66’140 274’981

Übrige Segmentinformationen

             
Investitionen Nutzungsrechte aus Leasing 1’165 861 1’597 3’623
Investitionen Sachanlagen und immaterielle Werte 6’586 1’870 3’011 11’467
Abschreibungen, Amortisationen und Wertberichtigungen 8’622 5’297 4’744 18’663
Veränderung Rückstellungen 262 -1’887 77 -1’549
Übriger nicht liquiditätswirksamer
Aufwand/Ertrag
-203 -293 -47 24 400 -119
Personalbestand am Jahresende 826 435 310 1’571
 

Segmente 2024 angepasst1

In thousands of CHF

Plasma
Control
Technologies
(PCT)

X-Ray
Systems
(IXS)

Industrial
X-Ray
Modules
(IXM)

Elimination of
intersegment
activity

Corporate

Consolidated

Net sales

           
External net sales 247,391 115,836 82,135 445,362
Intersegment sales 52 12,436 (12,488)

Total net sales

247,391 115,888 94,571 (12,488) 445,362

Segment operating income restated

37,856 (8,854) 9,474 (138) 38,338
Unallocated costs (2,478) (2,478)

Operating income restated

37,856 (8,854) 9,474 (138) (2,478) 35,861
lnterest income           2,587
lnterest (expenses)           (2,084)
Other financial expenses           (258)
Net losses on derivative fair value           (1,412)
Net gains on foreign exchange           3,173

Income before tax restated

          37,867
Income tax restated           (5,087)

Net income restated

          32,779
             

EBITDA restated

50,365 (4,306) 14,567 (138) (2,478) 58,011
EBITDA in % of net sales restated 20,4% (3.7%) 15,4%     13,0%
             

Assets and liabilities at Dec. 31, 2024

           
Segment assets restated 198,431 98,958 92,220 139,539 529,148
Segment liabilities restated (66,275) (48,355) (21,830) (69,591) (206,050)

Net assets restated

132,156 50,604 70,390 69,948 323,098

Other segment information

           
Additions to right-of-use asset 4,630 2,311 1,544 8,484
Additions to property, plant and equipment & intangible assets 6,502 2,475 3,803 12,779
Depreciation, amortization and impairment 12,510 4,548 5,093 22,150
Change in provisions restated (351) 45 (42) (348)
Other non-cash expense or (income) (1,724) (26) 400 (28) 511 (867)

1 angepasst, weitere Erläuterungen zu den Anpassungen finden Sie in Anmerkung 02.3 „Restatement” des Geschäftsberichts 2025.

Segmente 2023

In thousands of CHF

Plasma
Control
Technologies
(PCT)

X-Ray
Systems
(IXS)

Industrial
X-Ray
Modules
(IXM)

Elimination
of
intersegment
sales

Corporate

Consolidated

Net sales

           
External net sales 193,155 116,826 87,472 397,453
Intersegment sales 134 12,787 (12,921)

Total net sales

193,155 116,961 100,258 (12,921) 397,453

Segment operating income

7,192 671 19,580 761 28,204
Unallocated costs (3,226) (3,226)

Operating income

7,192 671 19,580 761 (3,226) 24,978
lnterest income 1,632
lnterest (expenses) (2,214)
Other financial expenses (178)
Net gains on derivative fair value 1,791
Net losses on foreign exchange (7,014)

Income before tax

18,994
lncome tax (3,606)

Net income

15,388
             

EBITDA

18,719 4,923 23,819 761 (3,226) 44,996
EBITDA in % of net sales 9,7% 4,2% 23,8%     11,3%
             

Assets and liabilities at Dec. 31, 2023

           
Segment assets 181,421 95,340 88,105 108,713 473,578
Segment liabilities (52,386) (44,018) (14,854) (66,228) (177,486)

Net assets

129,035 51,321 73,252 42,484 296,092

Other segment information

           
Additions to right-of-use asset 4,044 1,010 164 5,217
Additions to property, plant and equipment & intangible assets 19,224 3,282 3,907 26,413
Depreciation, amortization and impairment 11,527 4,252 4,239 20,018
Change in provisions (443) (894) 172 (1,165)
Other non-cash expense or (income) (74) 463 (44) 104 1,945 2,394
Number of employees at year-end 787 463 327 1,577

5-Jahresübersicht

In thousands of CHF

2025

2024
restated

2023

2022

2021

Net sales 457,044 445,362 397,453 586,395 513,721
Operating income 24,556 35,861 24,978 98,975 84,085
In % of net sales 5,4% 8,1% 6,3% 16,9% 16,4%
EBITDA 46,335 58,011 44,996 118,913 102,749
In % of net sales 10,1% 13,0% 11,3% 20,3% 20,0%
Net income 12,208 32,779 15,388 78,109 67,437
In % of net sales 2,7% 7,4% 3,9% 13,3% 13,1%
Free cash flow1 8,502 41,414 (584) 42,173 57,767
In % of net sales 1,9% 9,3% (0,1%) 7,2% 11,2%
Total assets 500,920 529,148 473,578 556,801 482,341
Shareholders' equity 308,769 323,098 296,092 331,532 274,981
In % of total assets 61,6% 61,1% 62,5% 59,5% 57,0%
Number of employees (year-end)          
Switzerland 705 690 586 647 565
International 1,127 1,120 991 1,116 1,006
Total 1,832 1,810 1,577 1,763 1,571

1 Net cash provided by operating activities and net cash (used in) investing activities, as per consolidated statement of cash flows.

Segmente 2025

In thousands of CHF

Plasma
Control
Technologies
(PCT)

X-Ray
Systems
(IXS)

Industrial
X-Ray
Modules
(IXM)

Elimination of
intersegment
activity

Corporate

Consolidated

Net sales

           
External net sales 257,102 110,804 89,137 457,044
Intersegment sales 12 9,941 (9,953)

Total net sales

257,102 110,816 99,078 (9,953) 457,044

Segment operating income

27,807 (11,646) 10,722 263 27,146
Unallocated costs (2,590) (2,590)

Operating income

27,807 (11,646) 10,722 263 (2,590) 24,556
lnterest income           2,321
lnterest (expenses)           (1,986)
Other financial expenses           (325)
Net losses on derivative fair value           1,326
Net gains on foreign exchange           (5,538)

Income before tax

          20,354
lncome tax           (8,146)

Net income

          12,208
             

EBITDA

40,407 (7,516) 15,771 263 (2,590) 46,335
EBITDA in % of net sales 15,7% (6,8%) 15,9%     10,1%
             

Assets and liabilities at Dec. 31, 2025

           
Segment assets 199,557 86,813 94,656 119,895 500,920
Segment liabilities (65,394) (42,262) (20,017) (64,478) (192,151)

Net assets

134,163 44,551 74,639 55,418 308,769

Other segment information

           
Additions to right-of-use asset 992 877 260 2,130
Additions to property, plant and equipment & intangible assets 35,284 35 7,196 42,515
Depreciation, amortization and impairment (12,600) (4,131) (5,049) (21,779)
Change in provisions (46) 55 157 (91) 75
Other non-cash expense or (income) 291 508 458 68 (2,346) (1,022)